Compare GSK plc (GSK) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? GSK plc trades at $52.7 (market cap $101.34B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.86. The key difference: GSK plc pays a 3.49% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none, and GSK plc is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| GSK | XDTE | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $61.18 | $44.76 |
52-Week Low | $36.20 | $36.00 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
XDTE (Roundhill S&P 500 0DTE Covered Call Strategy ETF) trades at $38.90, down 0.54% with a bullish technical signal from moving averages. The ETF employs a daily options strategy generating high dividend yields, with recent distributions ranging from $0.09 to $0.26 per share. Technical indicators show neutral oscillators with RSI at moderate levels, while support and resistance cluster around $39.
XDTE offers exceptional income generation through its 0DTE covered call strategy but faces significant NAV erosion risks despite S&P 500 highs. The ETF's high yield strategy appeals to income investors but requires careful monitoring of market volatility and payout sustainability. Recent analysis highlights the trade-off between income generation and capital preservation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
